Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;37(1):39-51.
doi: 10.1002/mds.28774. Epub 2021 Aug 27.

Cellular Prion Protein Mediates α-Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo

Tobias Thom  1 , Matthias Schmitz  1 , Anna-Lisa Fischer  1 , Angela Correia  1 , Susana Correia  1 , Franc Llorens  1   2   3 , Anna-Villar Pique  1   2   3 , Wiebke Möbius  4 , Renato Domingues  5 , Saima Zafar  1   6 , Erik Stoops  7 , Christopher J Silva  8 , Andre Fischer  9   10   11 , Tiago F Outeiro  5   12   13 , Inga Zerr  1
Affiliations
Free article

Cellular Prion Protein Mediates α-Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo

Tobias Thom et al. Mov Disord. 2022 Jan.
Free article

Abstract

Background: The cellular prion protein (PrPC ) is a membrane-bound, multifunctional protein mainly expressed in neuronal tissues. Recent studies indicate that the native trafficking of PrPC can be misused to internalize misfolded amyloid beta and α-synuclein (aSyn) oligomers.

Objectives: We define PrPC 's role in internalizing misfolded aSyn in α-synucleinopathies and identify further involved proteins.

Methods: We performed comprehensive behavioral studies on four transgenic mouse models (ThySyn and ThySynPrP00, TgM83 and TgMPrP00) at different ages. We developed PrPC -(over)-expressing cell models (cell line and primary cortical neurons), used confocal laser microscopy to perform colocalization studies, applied mass spectrometry to identify interactomes, and determined disassociation constants using surface plasmon resonance (SPR) spectroscopy.

Results: Behavioral deficits (memory, anxiety, locomotion, etc.), reduced lifespans, and higher oligomeric aSyn levels were observed in PrPC -expressing mice (ThySyn and TgM83), but not in homologous Prnp ablated mice (ThySynPrP00 and TgMPrP00). PrPC colocalized with and facilitated aSyn (oligomeric and monomeric) internalization in our cell-based models. Glimepiride treatment of PrPC -overexpressing cells reduced aSyn internalization in a dose-dependent manner. SPR analysis showed that the binding affinity of PrPC to monomeric aSyn was lower than to oligomeric aSyn. Mass spectrometry-based proteomic studies identified clathrin in the immunoprecipitates of PrPC and aSyn. SPR was used to show that clathrin binds to recombinant PrP, but not aSyn. Experimental disruption of clathrin-coated vesicles significantly decreased aSyn internalization.

Conclusion: PrPC 's native trafficking can be misused to internalize misfolded aSyn through a clathrin-based mechanism, which may facilitate the spreading of pathological aSyn. Disruption of aSyn-PrPC binding is, therefore, an appealing therapeutic target in α-synucleinopathies. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Keywords: cellular prion protein; α-synuclein; α-synucleinopathies.

PubMed Disclaimer

References

    1. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997;388(6645):839-840.
    1. Bendor JT, Logan TP, Edwards RH. The function of alpha-synuclein. Neuron 2013;79(6):1044-1066. https://doi.org/10.1016/j.neuron.2013.09.004
    1. Goedert M, Jakes R, Spillantini MG. The synucleinopathies: twenty years on. J Parkinsons Dis 2017;7(s1):S51-S69.
    1. Bras IC, Dominguez-Meijide A, Gerhardt E, et al. Synucleinopathies: where we are and where we need to go. J Neurochem 2020;153(4):433-454.
    1. Lashuel HA, Overk CR, Oueslati A, Masliah E. The many faces of alpha-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci 2013;14(1):38-48.

Publication types